Check out the news on OPK and RXII and there swap . OPK now holds 50 ml shares of RXII . RXii has gene technology that its founder DR. Wolf won a Nobel Prize for a few years back , started the company ran out of money ,and sold out to Gale a few years ago , they took what they wanted out, and re-flooted RXII for cents . According to ALQAs CEO today said that they were looking for mergers and companys to buy . MY thinking is that ALQA will buy, or merge with RXII , and or OPK could end up with both companys and Dr. Frost will make another few hundred million on the mergers . Note RXII and ALQA are both dermatology and wound healing companys witch is Dr Frost thing ! I have shares in all three companys . I wonder how many shares in RXII DR. Frost and Frost-Gamma have bought today . Good luck to all !
I't looks like ALQA hopefully will be getting the contract to do some work for the company OPK just sold RNA projects to. They have rxi-109 a potential treatment for dermal scarring that is in rapid advancement. Dr.Frost was a Dermatologist and owns shares in ALQA. It is a step in the right direction for future revenue if rxi-109 will be applied by transderal applications imo..